The largest database of trusted experimental protocols

Gsk484

Manufactured by Cayman Chemical
Sourced in United States

GSK484 is a small molecule compound that functions as a potent and selective inhibitor of the Jumonji C (JmjC) domain-containing histone demethylase JMJD3. It exhibits an IC50 value of approximately 30 nM for JMJD3 inhibition. GSK484 can be utilized in research applications involving the investigation of the biological roles of JMJD3 and its associated epigenetic regulation.

Automatically generated - may contain errors

19 protocols using gsk484

1

Inflammasome Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following reagents were used: ultra-pure LPS, nigericin, poly(deoxyadenylic-deoxythymidylic) acid [poly(dA:dT)]/lyoVec, BAPTA-AM, calcium-free DMEM, disuccinimidyl suberate, Lipofectamine 2000 (all Invivogen), calcium chloride solution, thapsigargin, ATP (Sigma-Aldrich), CI-amidine (Millipore), BB-CI-amidine and GSK484 (Cayman Chemicals), AFM 30a (P. Thompson, University of Massachusetts Medical School, Worcester, MA) (21 (link)), iScript cDNA kit and iQ SYBR green supermix (BioRad), TRIzol (Ambion, Life technologies), fixation/permeabilization solution, mouse IL-1β ELISA kit (BD Bioscience), propidium iodide (ImmunoChemistry Technologies) and mouse TNF- alpha ELISA (eBioscience). Abs for confocal microscopy were ASC (AdipoGen), peptidyl-citrulline, clone F95 (Millipore), anti-vimentin (Abcam), goat anti-rabbit IgG AF647, goat anti-mouse IgM AF488 (Thermo Fisher Scientific), and goat anti-mouse IgM isotype control (SouthernBiotech). DAPI was from Molecular Probes.
+ Open protocol
+ Expand
2

Protocols for Culturing Multiple Myeloma Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human MM RPMI-8226 and MM1.S cell lines were obtained from ATCC (Manassas, VA). Mouse MM DP42 cell line was a gift from Dr. Van Ness (University of Minnesota); 5TGM1 cell line was provided by Dr. Oyajobi (UT Health San Antonio). All MM cells were cultured in RPMI-1640 medium supplemented with L-glutamine, 10% fetal bovine serum (FBS), and 1% antibiotic-antimycotic. DP42 cells were also supplemented with 0.5 ng/mL murine IL-6 (Cat.#406-ML, R&D Systems). Cell lines were Mycoplasma negative as detected by PCR. Cells were maintained in culture for a maximum of 6 weeks.
BMS-P5, ((cis)-5-Amino-2-methylpiperidin-1-yl)(2-(1-(cyclopropylmethyl)-1H-pyrrolo[2,3-b]pyridine-2-yl)-7-methoxy-1-methyl-1H-benzo[d]imidazole-5-yl)methanone, hydrochloride) (Example 24, patent US9127003B2) (28 ) was provided by Bristol-Myers Squibb (BMS, Princeton, NJ). Cl-amidine (Cl-A, Cat.#10599) and GSK-484 (Cat.#17488) were purchased from Cayman Chemical (Ann Arbor, MI) and Calcium ionophore (CaIo, Cat.#A23187) was obtained from Sigma-Aldrich (St.Louis, MO).
+ Open protocol
+ Expand
3

PD-L1 Expression Modulation in DU145 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DU145 cells were plated as described above, and allowed to adhere for 24 h. After 24 h, cells were treated with either 100 units/mL of human interferon gamma (IFN-γ) (300–02, Pepro Tech, Rocky Hill, Connecticut, USA), or one of the following drugs at a concentration at approximately the published IC50 on the manufacturer’s product page: 0.01 μM GSK591 (S8111, Selleckchem), 0.1 μM GSK484 (17,488, Cayman Chemicals, Michigan, USA), 0.1 μM MS049 (18,348, Cayman Chemicals), 0.1 μM SGC707 (S7832, Selleckchem), 0.01 μM GSK343 (S7164, Selleckchem), 0.1 μM LLY-507 (S7575, Selleckchem), 0.1 μM A-196 (S7983, Selleckchem), 0.1 μM JQ1 (S7110, Selleckchem), 0.1 μM NVS-1 (5744, Tocris Biosciences, Bristol, UK), 0.1 μM LP-99 (17,661, Cayman Chemicals), 0.1 μM Entinostat (S1053, Selleckchem), or 0.1 μM 5-Azacytidine (S1782, Selleckchem) for 48 h prior to harvest. Cells were stained with Brilliant Violet 421™ (BV421) mouse anti-human PD-L1 1:50 (CD274, Clone 29E.2A3, BioLegend, San Diego, CA, USA) and eFluor™ 780 fixable viability dye 1:10000 (65,086,514, Invitrogen, Waltham, MA, USA) using the flow cytometry process detailed below.
+ Open protocol
+ Expand
4

Optimizing Differentiation of Podocytes and Glomerular Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Conditionally immortalized mouse and human podocytes and human glomerular endothelial cells (hGENCs) were grown on 10 cm2 cell culture plates at 33 °C in the presence of interferon γ (10 U/mL), which enhances expression of the thermosensitive T antigen. These conditions are optimum for cells to proliferate and remain undifferentiated. To induce differentiation, thermoswitching was performed at 37 °C in the absence of interferon γ and the addition of 100 ng/mL vascular endothelial growth factor (VEGF). Experiments were performed after 7 days of differentiation for hGENCs and 14 days of differentiation for mouse and human podocytes. Mouse and human primary glomerular endothelial cells were obtained from cell biologicals, and 2.2 × 106 cells were cultured onto 0.02% gelatin-coated plates at 37 °C in (M-6115 and H-6115 media from cell biologicals). All the cell lines tested negative for mycoplasma. In some experiments, cultured cells were treated with 25 mM glucose (SIGMA, G8769) and/or 10,000 neutrophils, 10 µM GSK484 (Cayman, 17488) for 24 h. Cells cultured under normal glucose (5 mM) or 25 mM mannitol were used as controls.
+ Open protocol
+ Expand
5

Neutrophil Extracellular Trap (NET) Isolation and Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified neutrophils (500,000) isolated from GC patients or healthy controls were subsequently incubated at 37°C in 5% CO2 then activated overnight with 25 nM PMA (#P1585, phorbol 12-myristate 13-acetate, Sigma-Aldrich; Merck KGaA). In the inhibition assay, PMA and the inhibitors were used in combination. NETs inhibitors were added 30 min prior to neutrophil activation to inhibit NETs formation. The PAD4 inhibitor, GSK484 (#17488, Cayman Chemical Company) was used at 10 µM to inhibit NETs formation, and 1.5 units/ml of DNase I (#04536282001, Sigma-Aldrich; Merck KGaA) was used to digest NETs scaffolds. The supernatant containing NETs was collected and centrifugation at 250 × g for 10 min at room temperature. Isolated NETs were stored at −80°C until further use as previously reported (28 (link)). To investigate the effect of the TME on NETs formation, neutrophils were treated using 20% plasma from the same patients with GC (n=20) or the controls (n=10) as above, following a previously described protocol (29 (link)).
+ Open protocol
+ Expand
6

Ruxolitinib and PAD4 Inhibition in NET Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
For ex vivo experiments, ruxolitinib (Selleckchem) was used at a concentration of 300 nM for 150 min. For in vivo experiments, mice were gavaged with 90 mg/kg of ruxolitinib or vehicle (5% dimethylacetamide, DMAC, Sigma-Aldrich) twice daily for 3 days (6 doses) as previously described (40 (link)). For the ex vivo NET inhibition assay, we used a PAD4 inhibitor (GSK 484 at 10 µM) as a negative control (Cayman chemical).
+ Open protocol
+ Expand
7

CLP-Induced Sepsis Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sepsis was induced by CLP. Briefly, the peritoneal cavity was opened under inhaled isoflurane anesthesia. The cecum was eviscerated, ligated below the ileocecal valve using a 5-0 silk suture at 75% from the tip, and punctured through with a 21-gauge needle. Sham-operated animals were handled in the similar manner, except the cecum was not ligated and punctured. For the survival study, mice were monitored for 7 days. For mechanistic studies, mice were sacrificed at their respective time point. For inhibitor analysis, PAD4 inhibitor GSK484 (40 mg/kg) (Cayman Chemical, 17488), PAD2 inhibitor AFM32a (20 mg/kg), which was synthesized as previously described (65 (link)), or DMSO alone was i.p. injected 1 hour after CLP.
+ Open protocol
+ Expand
8

Peritonitis Induction and Phagocytosis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce peritonitis, mice were injected intra-peritoneally with either 0.5mg Zymosan-A (Sigma) in PBS, 0.25mg of Fluorescein labeled Zymosan-A (Invitrogen), or PBS alone and samples were isolated 2-72 h later. To block NETosis, mice were injected i.p. with 400 μg/mouse of GSK484 (Cayman Chemical). Blocking antibodies against CXCL1 (Clone 48415, Invitrogen) or isotype control Rat IgG2a (Invitrogen) antibodies were injected i.p. 2 h after induction of peritonitis (40 μg/mouse). Following Zymosan and anti-CXCL1 treatment, omenta were isolated and cultured with mCherry E. coli (Amarh et al., 2018 (link)) or E. coli bioparticles (Invitrogen) in vitro for 5 min prior to thorough washing with RPMI-1640 (Sigma), and wholemount staining as described below.
Peritoneal exudate cells (PEC) were isolated by flushing murine peritoneal cavities with RPMI 1640 (Sigma). Murine omenta were enzymatically digested with 1mg/mL Collagenase D (Roche) for 35 min at 37°C in RPMI 1640 (Sigma) containing 1% Fetal Bovine Serum (FBS) (Sigma). Spleens were mechanically disrupted using glass slides.
+ Open protocol
+ Expand
9

Neutrophil Chemotaxis Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutrophil chemotaxis was measured using 3 μm pore transwell system (Neuro Probe Inc. or Sigma-Aldrich). Advanced RPMI 1640 medium with CXCL1 (BioLegend) or fMLP (Sigma-Aldrich) was placed in the bottom of the well whereas neutrophils (0.1 × 106 cells) resuspended in Advanced RPMI 1640 medium were placed on the top of Transwell insert. In some experiments, neutrophils were pre-incubated with 10 μM GSK484 (Cayman) for 30min prior to being placed on the top of the Transwell insert. Plates were kept for at 37°C in 5% CO2 for 1h followed by counting migrated cells in the bottom well.
+ Open protocol
+ Expand
10

NET Formation Inhibition and Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols

NET experiments were based on a co-culture of neutrophils (1 × 10
5) and platelets (1 × 10
7). Cells were activated by the calcium ionophore A23187 (4 µM) in the absence or presence of the NETosis inhibitor GSK484 at 2 mM (Cayman Chemicals, Ann Arbor, Michigan, United States). Where indicated, 50 µM cathepsin G inhibitor and 1 mM elastase inhibitor were added (concomitantly with GSK484), then incubated for 30 minutes before stimulation with A23187. NETs generated by activated neutrophils were digested with 500 mU/mL micrococcal nuclease (Sigma-Aldrich) for 10 minutes and culture supernatant was retrieved by centrifugation at 5,000 × 
gfor 90 seconds for immunoblotting of TSP-1 and citrullinated histone H3 (citH3) or for elastase activity assays (BioVision, Milpitas, California, United States) conducted according to the manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!